![Comprehensive characterization of RAS mutations in colon and rectal cancers in old and young patients | Nature Communications Comprehensive characterization of RAS mutations in colon and rectal cancers in old and young patients | Nature Communications](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41467-019-11530-0/MediaObjects/41467_2019_11530_Fig1_HTML.png)
Comprehensive characterization of RAS mutations in colon and rectal cancers in old and young patients | Nature Communications
![Tumor microenvironment-adjusted prognostic implications of the KRAS mutation subtype in patients with stage III colorectal cancer treated with adjuvant FOLFOX | Scientific Reports Tumor microenvironment-adjusted prognostic implications of the KRAS mutation subtype in patients with stage III colorectal cancer treated with adjuvant FOLFOX | Scientific Reports](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41598-021-94044-4/MediaObjects/41598_2021_94044_Fig1_HTML.png)
Tumor microenvironment-adjusted prognostic implications of the KRAS mutation subtype in patients with stage III colorectal cancer treated with adjuvant FOLFOX | Scientific Reports
![Detection of KRAS mutation using real-time polymerase chain reaction... | Download Scientific Diagram Detection of KRAS mutation using real-time polymerase chain reaction... | Download Scientific Diagram](https://www.researchgate.net/publication/26858791/figure/fig3/AS:601604969488397@1520445210787/Detection-of-KRAS-mutation-using-real-time-polymerase-chain-reaction-PCR-amplification.png)
Detection of KRAS mutation using real-time polymerase chain reaction... | Download Scientific Diagram
![KRAS testing is a screening of non-responders to anti-EGFR therapy.... | Download Scientific Diagram KRAS testing is a screening of non-responders to anti-EGFR therapy.... | Download Scientific Diagram](https://www.researchgate.net/publication/51761761/figure/fig1/AS:393900016586757@1470924490835/Fig-1-KRAS-testing-is-a-screening-of-non-responders-to-anti-EGFR-therapy.png)
KRAS testing is a screening of non-responders to anti-EGFR therapy.... | Download Scientific Diagram
![Genetic analysis of KRAS mutation status in metastatic colorectal cancer patients. | Semantic Scholar Genetic analysis of KRAS mutation status in metastatic colorectal cancer patients. | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/6091c75efde25a8c40f4b39872ab78e61eacbb4c/3-Table2-1.png)
Genetic analysis of KRAS mutation status in metastatic colorectal cancer patients. | Semantic Scholar
![RAS genes in colorectal carcinoma: pathogenesis, testing guidelines and treatment implications | Journal of Clinical Pathology RAS genes in colorectal carcinoma: pathogenesis, testing guidelines and treatment implications | Journal of Clinical Pathology](https://jcp.bmj.com/content/jclinpath/72/2/135/F1.large.jpg)
RAS genes in colorectal carcinoma: pathogenesis, testing guidelines and treatment implications | Journal of Clinical Pathology
Evaluation of KRAS, NRAS and BRAF hotspot mutations detection for patients with metastatic colorectal cancer using direct DNA pi
![Diagnostics | Free Full-Text | Sensitive Detection of KRAS Mutations by Clustered Regularly Interspaced Short Palindromic Repeats Diagnostics | Free Full-Text | Sensitive Detection of KRAS Mutations by Clustered Regularly Interspaced Short Palindromic Repeats](https://www.mdpi.com/diagnostics/diagnostics-11-00125/article_deploy/html/images/diagnostics-11-00125-g001.png)
Diagnostics | Free Full-Text | Sensitive Detection of KRAS Mutations by Clustered Regularly Interspaced Short Palindromic Repeats
![Effects of KRAS, BRAF, NRAS, and PIK3CA mutations on the efficacy of cetuximab plus chemotherapy in chemotherapy-refractory metastatic colorectal cancer: a retrospective consortium analysis - The Lancet Oncology Effects of KRAS, BRAF, NRAS, and PIK3CA mutations on the efficacy of cetuximab plus chemotherapy in chemotherapy-refractory metastatic colorectal cancer: a retrospective consortium analysis - The Lancet Oncology](https://www.thelancet.com/cms/attachment/3874fcad-2672-4bd9-887d-fb413e55795d/gr1_lrg.jpg)
Effects of KRAS, BRAF, NRAS, and PIK3CA mutations on the efficacy of cetuximab plus chemotherapy in chemotherapy-refractory metastatic colorectal cancer: a retrospective consortium analysis - The Lancet Oncology
![Analytical performance of a PCR assay for the detection of KRAS mutations (codons 12/13 and 61) in formalin-fixed paraffin-embedded tissue samples of colorectal carcinoma | Virchows Archiv Analytical performance of a PCR assay for the detection of KRAS mutations (codons 12/13 and 61) in formalin-fixed paraffin-embedded tissue samples of colorectal carcinoma | Virchows Archiv](https://media.springernature.com/lw685/springer-static/image/art%3A10.1007%2Fs00428-011-1180-0/MediaObjects/428_2011_1180_Fig1_HTML.gif)
Analytical performance of a PCR assay for the detection of KRAS mutations (codons 12/13 and 61) in formalin-fixed paraffin-embedded tissue samples of colorectal carcinoma | Virchows Archiv
![A saturation mutagenesis screen uncovers resistant and sensitizing secondary KRAS mutations to clinical KRASG12C inhibitors | PNAS A saturation mutagenesis screen uncovers resistant and sensitizing secondary KRAS mutations to clinical KRASG12C inhibitors | PNAS](https://www.pnas.org/cms/asset/6d084523-3472-43c3-9819-1416a619ce47/keyimage.jpg)
A saturation mutagenesis screen uncovers resistant and sensitizing secondary KRAS mutations to clinical KRASG12C inhibitors | PNAS
![IJMS | Free Full-Text | Gene Therapy Targeting p53 and KRAS for Colorectal Cancer Treatment: A Myth or the Way Forward? IJMS | Free Full-Text | Gene Therapy Targeting p53 and KRAS for Colorectal Cancer Treatment: A Myth or the Way Forward?](https://pub.mdpi-res.com/ijms/ijms-22-11941/article_deploy/html/images/ijms-22-11941-g001.png?1636353558)